Management of Lasunathabitham with siddha formulation

An open clinical trial for the management of Acute Pharyngo Tonsillitis (Lasunathabitham) in children with poly herbal formulation of Lasunathabitha Mathirai among patients attending Ayothidoss Pandithar Hospital, National institute of Siddha - NIL

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2026/06/111883

Enrollment

Registered

2026-06-04

Start date

Unknown

Completion date

Unknown

Last updated

2026-06-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: J039- Acute tonsillitis, unspecified

Interventions

Intervention1: Lasunathabitha mathirai : 1 tablet -400mg Bd for 48 days Control Intervention1: Not applicable: Not applicable

Eligibility

Inclusion criteria

Inclusion criteria: Children with age group of 7 to 12 years Sex:male and female children Enlarged tonsils with Brodsky scale Grade 2 and above Clinical scoring for acute pharyngo tonsillitis 4to 8

Exclusion criteria

Exclusion criteria: Oral candidiasis: Children with white pseudo membrane patches on tongue/oropharynx/ hard and soft palate were excluded. K/C/O Tuberculosis Peritonsillar abscess: Children with symptoms like abscess near tonsil, trismus will be excluded. Tonsillar hemorrhage

Design outcomes

Primary

Measure	Time frame
Efficacy of the trial drug will be assessed based on Brodsky scale and clinical scoring for acute pharyngo tonsillitisTimepoint: 48 days	—

Secondary

Measure	Time frame
NILTimepoint: NIL	—

Countries

India

Contacts

Public ContactDr M Meenakshi sundaram

National Institute of siddha

mmssiddha@rediffmail.com9444214582

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Jun 29, 2026